Instil Bio TIL
NASDAQ TIL
$7.22 -0.02 (-0.28%)
At close: Oct 2, 2026 · 4:00 PM EDT

Instil Bio (TIL) Gains from Sales and Divestitures (2022 - 2026)

Updated

Instil Bio's Gains from Sales and Divestitures came in at -$2,000 for Q1 2026.

Analysis

Instil Bio (TIL) Gains from Sales and Divestitures (2022 - 2026) Analysis & Trends

For FY2024, Instil Bio's Gains from Sales and Divestitures was -$343,000.

  • Going back by year, Gains from Sales and Divestitures was -$377,000 in FY2023.
  • The Q1 2026 figure represents the highest quarterly Gains from Sales and Divestitures since Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Instil Bio 48.97 Mn 48.97 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -2,000.00
Sep 30, 2024 -51,000.00
Mar 31, 2024 -292,000.00
Dec 31, 2023 -39,000.00
Sep 30, 2023 -3,000.00
Jun 30, 2023 -290,000.00
Mar 31, 2023 -45,000.00
Dec 31, 2022 240,000.00
Sep 30, 2022 -37,000.00
Jun 30, 2022 -203,000.00
API Access

Instil Bio Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=TIL&period=max&api_key=YOUR_API_KEY